Biblio

Found 7 results
Filters: Keyword is Gene Expression Regulation, Neoplastic  [Clear All Filters]
2015
Moutal A, Honnorat J, Massoma P, Désormeaux P, Bertrand C, Malleval C, Watrin C, Chounlamountri N, Mayeur M-E, Besançon R et al..  2015.  CRMP5 Controls Glioblastoma Cell Proliferation and Survival through Notch-Dependent Signaling.. Cancer Res. 75(17):3519-28.
Samulitis BK, Pond KW, Pond E, Cress AE, Patel H, Wisner L, Patel C, Dorr RT, Landowski TH.  2015.  Gemcitabine resistant pancreatic cancer cell lines acquire an invasive phenotype with collateral hypersensitivity to histone deacetylase inhibitors.. Cancer Biol Ther. 16(1):43-51.
2012
Jandova J, Beyer TE, Meuillet EJ, Watts GS.  2012.  The matrix protein CCN1/CYR61 is required for α(V)β5-mediated cancer cell migration.. Cell Biochem Funct. 30(8):687-95.
2007
Watts GS, Tran NL, Berens ME, Bhattacharyya AK, Nelson MA, Montgomery EA, Sampliner RE.  2007.  Identification of Fn14/TWEAK receptor as a potential therapeutic target in esophageal adenocarcinoma.. Int J Cancer. 121(10):2132-9.
2006
Novak P, Jensen T, Oshiro MM, Wozniak RJ, Nouzova M, Watts GS, Klimecki WT, Kim C, Futscher BW.  2006.  Epigenetic inactivation of the HOXA gene cluster in breast cancer.. Cancer Res. 66(22):10664-70.
2004
Watts GS, Oshiro MM, Junk DJ, Wozniak RJ, Watterson S, Domann FE, Futscher BW.  2004.  The acetyltransferase p300/CBP-associated factor is a p53 target gene in breast tumor cells.. Neoplasia. 6(3):187-94.
2003
Oshiro MM, Watts GS, Wozniak RJ, Junk DJ, Munoz-Rodriguez JL, Domann FE, Futscher BW.  2003.  Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression.. Oncogene. 22(23):3624-34.